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Available online 6 December 2012We present the case of a young (34 years) previously ﬁt and
well woman who was admitted to our ICU for the management
of severe septic shock following faecal peritonitis. She did not
have any traditional cardiovascular risk factors and performed
regular strenuous exercises at the local gymnasium until imme-
diately prior to her illness. Forty eight hours after admission
she developed an inferior ST-elevation myocardial infarction
(STEMI). Troponin-T levels were elevated at 2.1 ng ml1 1 h
after ﬁrst complaining of chest pain and 4.12 ng ml1 12 h later.
The corresponding EKG at the time of the chest pain is shown
in Fig. 1. ECHO cardiogram showed the presence of regional
wall motion abnormalities and an ejection fraction of 45%.
She was managed conservatively and made a complete recov-
ery. Coronary angiogram performed 5 weeks later was normal
(Fig. 2A and B). This case history raises the question as to why
a young woman with a normal coronary circulation developed
STEMI during a septic illness.
In this context, we report a series of 7 patients with septic
shock and impaired cardiac ejection fraction (EF) who under-
went myocardial perfusion scans during the acute stage at the
in-house Nuclear Cardiology Facility, Critical Care Unit, Uni-
versity of Cairo, Egypt. Standard Tc-99 perfusion scans were* Corresponding author. Address: Department of Critical Care Med-
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9WL, UK. Tel.: +44 161 276 4551.
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5–7 days later. All 7 patients had reversible perfusion defects
either within a single well deﬁned coronary territory or with
a more patchy distribution that did not correlate to a single
coronary territory. The perfusion defects were reversible to
varying degrees in all 7 patients (Using an objective 20 segment
scoring systems the mean ± SD perfusion defects were
17.7 ± 5.7 Vs 7 ± 5.9) with two patients showing complete
reversibility (Fig. 3). At the time of the repeat perfusion scans
ventricular function too had recovered in all but one patient
(Mean EF: 46 ± 2 Vs 56 ± 7%).
Myocardial dysfunction seen in patients with severe sepsis
may be attributed to a variety of factors including ischaemia,
pro-inﬂammatory cytokines (systemic or local), NO, oxidative
stress or acidosis [1]. Elevation of Troponin I – used in the def-
inition of septic cardiomyopathy by some authors [2,3], is in
fact a biomarker of myocardial damage and supports the view
that ischemia may indeed be an important aetiological factor.
Ischaemia in these subjects could be relative due to a myocar-
dial oxygen supply–demand imbalance brought about by sinus
tachycardia and hypotension – particularly in subjects with pre-
existing ﬁxed coronary narrowing. Cunnion et al. [4] and Dhai-
naut et al. [5] have demonstrated that coronary sinus blood ﬂow
was normal or increased in patients with septic shock. Further-
more, net myocardial lactate extraction and myocardial oxygen
availability were by and large normal in sepsis. These observa-
tions have been used to support the view that ischaemia was an
unlikely cause of septic septic cardiomyopathy. In this context,
our present case report demonstrating STEMI – in the presence
of a normal coronary circulation, and reversible perfusion
defects in patients with septic shock raises the possibility of
transient coronary occlusion in patients with septic shock. It07.001
n and hosting by Elsevier B.V.
Figure 1 ECG: time of chest pain showing inferior STEMI.
Figure 2 Normal coronary angiogram performed 5 weeks after an inferior STEMI.
Figure 3 Myocardial perfusion defects (arrows) on admission (left panel) and – hours after admission (right panel) in 2 patients with
septic shock. Partial (A) or complete (B) reversibility of perfusion defects is clearly evident (the stress score refers to the admission scans
and the rest score refers to the repeat scans).
22 M.M. Khaled et al.is well recognised that intravascular coagulation and microvas-
cular thrombosis are important components of severe sepsis [6].
Microvascular thrombosis may involve the coronary circula-tion too and account for some of the key manifestations
associated with septic cardiomyopathy. The underlying ischae-
mia may be large/overt (as in theManchester patient) when one
Reversible myocardial ischaemia in septic shock: Case series 23of the major arteries is involved or silent (the Cairo series) if
only the smaller peripheral tributaries are occluded.
The possibility of microcirculatory abnormalities within
the coronary circulation has been suggested by previous
authors too [1]. The perfusion scans provided in this report
provide the ﬁrst direct evidence to this phenomenon. The role
of circulating and local humoral factors [7–9] in causing global
contractile dysfunction is now well established in sepsis.
Deﬁning the role of ischaemia in septic cardiomyopathy is
important as the common treatment strategy based on aggres-
sive volume resuscitation and large doses of vasoconstrictor
agents such as norepinephrine may be particularly counter-
productive in the presence of overt or silent myocardial
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